GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » Forward Dividend Yield %

Alkem Laboratories (NSE:ALKEM) Forward Dividend Yield % : 0.88% (As of May. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories Forward Dividend Yield %?

As of today (2024-05-11), the Forward Annual Dividend Yield of Alkem Laboratories is 0.88%.

As of today (2024-05-11), the Trailing Annual Dividend Yield of Alkem Laboratories is 0.88%.

NSE:ALKEM's Forward Dividend Yield % is ranked worse than
73.43% of 493 companies
in the Drug Manufacturers industry
Industry Median: 1.85 vs NSE:ALKEM: 0.88

Alkem Laboratories's Dividends per Share for the three months ended in Dec. 2023 was ₹0.00.

During the past 12 months, Alkem Laboratories's average Dividends Per Share Growth Rate was -26.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -14.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 11.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Alkem Laboratories was 71.00% per year. The lowest was -14.10% per year. And the median was 23.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Alkem Laboratories's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's Forward Dividend Yield % falls into.



Alkem Laboratories Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Alkem Laboratories Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
INR 35.0000002024-02-162024-02-172024-03-01Cash Dividendsemi-annuallyINR:INR 1.000000
INR 10.0000002023-08-102023-08-102023-08-30Cash Dividendsemi-annuallyINR:INR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Alkem Laboratories's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=70/5128.90
=1.36 %

Current Share Price is ₹5128.90.
Alkem Laboratories's Dividends per Share for the forward twelve months is calculated as ₹35 * 2 = ₹70.

Alkem Laboratories's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=45/5128.90
=0.88 %

Current Share Price is ₹5128.90.
Alkem Laboratories's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹45.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alkem Laboratories  (NSE:ALKEM) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Alkem Laboratories Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkem Laboratories (NSE:ALKEM) Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines